Trial Site Detail

 

Drug:
QINLOCK Ripretinib DCC-2618
Trial:
Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies (invictus)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting

 

Institut Bergonie

229 Cours Argonne     
Bordeaux , Gironde 33076
France

 

Principal Investigator:
Binh Bui Nguyen, MD
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Institut Bergonie Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.